AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
RIVAROXABAN in Côte d'Ivoire
24 products registered with AIRP — 16 active, 8 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VAROSUN 10MG COMPRIME PELLICULE BOITE DE 14 | MD/8O1222-0207 | SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL | active | 3 Apr 2029 |
| VAROSUN 20MG COMPRIME PELLICULE BOITE DE 14 | MD/8O1222-0208 | SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL | active | 3 Apr 2029 |
| XARELTO 10MG COMPRIME PELLICULE BOITE DE 10 | E-2011-200 | BAYER WEST & CENTRAL AFRICA | active | 4 Aug 2026 |
| RIBAX 10MG COMPRIME BOITE DE 10 | E-2019-1353 | GENIX PHARMA PVT LTD | expired | 9 Oct 2024 |
| RIBAX 20MG COMPRIME BOITE DE 14 | E-2019-1354 | GENIX PHARMA PVT LTD | expired | 9 Oct 2024 |
| Z-COT 20MG COMPRIME BOITE DE 30 | E-2019-0777 | AJANTA PHARMA | expired | 6 Feb 2024 |
| RIXA-GH 20MG COMPRIME BOITE DE 14 | E-2018-0180 | GENERIC HEALTHCARE PVT. LTD | expired | 24 Jan 2023 |
| RIXA-GH 10MG COMPRIME BOITE DE 10 | E-2018-0181 | GENERIC HEALTHCARE PVT. LTD | expired | 24 Jan 2023 |
| RIXA-GH 15MG COMPRIME BOITE DE 10 | E-2018-0182 | GENERIC HEALTHCARE PVT. LTD | expired | 24 Jan 2023 |
| XARELTO 15MG COMPRIME PELLICULE BOITE DE 14 | MD/201323-0023 | BAYER WEST & CENTRAL AFRICA | expired | 26 Mar 2018 |
| XARELTO 20MG COMPRIME PELLICULE BOITE DE 14 | MD/201323-0022 | BAYER WEST & CENTRAL AFRICA | expired | 26 Mar 2018 |
| REXABAN 10 MG COMPRIME PÉLLICULE BOÎTE DE 10 | MD/2O0425/0002 | AFRIC-PHAR | active | — |
| REXABAN 15 MG COMPRIME PÉLLICULE BOÎTE DE 28 | MD/2O0425/0003 | AFRIC-PHAR | active | — |
| ROXABAN-DENK 15 MG COMPRIME PELLICULE BOITE DE 28 | MD/2O0425/0012 | DENK PHARMA GmbH & Co.KG | active | — |
| ROXABAN-DENK 20 MG COMPRIME PELLICULE BOITE DE 29 | MD/2O0425/0013 | DENK PHARMA GmbH & Co.KG | active | — |
| OXABAN 10, 10 MG COMPRIMÉ PELLICULÉ, BOÎTE DE 20 | MD/2O0724/0028 | LABORATORIRES SN INTERNATIONAL MIDDLE EAST | active | — |
| ARIXA 15MG COMPRIME BOITE DE 30 | E-2019-1004 | SCILIFE PHARMA (PVT) LTD | active | — |
| ARIXA 20MG COMPRIME BOITE DE 30 | E-2019-1005 | SCILIFE PHARMA (PVT) LTD | active | — |
| ROXPINN 10 10MG COMPRIME BOITE DE 30 | MD/201924/0419 | PINNACLE LIFE SCIENCE PVT.LTD | active | — |
| ARIXA 10MG COMPRIME BOITE DE 30 | E-2019-1003 | SCILIFE PHARMA (PVT) LTD | active | — |
| OXABAN 20, 20 MG COMPRIMÉ PELLICULÉ, BOÎTE DE 28 | MD/2O0724/0030 | LABORATORIRES SN INTERNATIONAL MIDDLE EAST | active | — |
| REXABAN 20 MG COMPRIME PÉLLICULE BOÎTE DE 28 | MD/2O0425/0004 | AFRIC-PHAR | active | — |
| ROXPINN 20 MG COMPRIME BOÎTE DE 30 | MD/201924/0420 | PINNACLE LIFE SCIENCE PVT. LTD | active | — |
| OXABAN 15, 15 MG COMPRIMÉ PELLICULÉ, BOÎTE DE 28 | MD/2O0724/0029 | LABORATORIRES SN INTERNATIONAL MIDDLE EAST | active | — |
RIVAROXABAN — AIRP Registration Details
AIRP (Côte d'Ivoire) has 24 registered products containing RIVAROXABAN, of which 16 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track RIVAROXABAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.